Cash Dividend On The Way From MainSource Financial Group (MSFG)

Looking at the universe of stocks we cover at Dividend Channel, on 6/3/15, MainSource Financial Group Inc (MSFG) will trade ex-dividend, for its quarterly dividend of $0.13, payable on 6/15/15. As a percentage of MSFG's recent stock price of $20.25, this dividend works out to approximately 0.64%, so look for shares of MainSource Financial Group Inc to trade 0.64% lower — all else being equal — when MSFG shares open for trading on 6/3/15.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for MSFG, showing historical dividends prior to the most recent $0.13 declared by MainSource Financial Group Inc:

MSFG+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from MSFG is likely to continue, and whether the current estimated yield of 2.57% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of MSFG shares, versus its 200 day moving average:

MainSource Financial Group Inc 200 Day Moving Average Chart

Looking at the chart above, MSFG's low point in its 52 week range is $15.91 per share, with $21.08 as the 52 week high point — that compares with a last trade of $20.25.

In Monday trading, MainSource Financial Group Inc shares are currently up about 1.1% on the day.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says